← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Enantigen Therapeutics, Inc.
Doylestown, PA
$1,177,154
Total funding
4
Grants
Funding over time
peak $594.7K · FY2009–13$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,177,154 · 4
By mechanism
R43$1,177,154 · 4
Investigators at Enantigen Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Discovery of Anti-HBV cccDNA Compounds from a Unique Natural Products Collection$300,000
R43 · FY2013 · AI
Development of Sulfamoylbenzamide Derivatives as Antiviral Agents against HBV Inf$300,000
R43 · FY2012 · AI
Development of Fluorinated Sulfamoylbenzamide Derivatives as Antiviral Agents aga$294,674
R43 · FY2013 · AI
Development of a Therapy for Dengue Virus Infection$282,480
R43 · FY2009 · AI